Enzolytics Inc.
ENZC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | 0.78 | -0.09 | 3.06 |
| FCF Yield | -45.88% | -1.72% | -2.55% | -0.76% |
| EV / EBITDA | -6.64 | -24.58 | -36.36 | -313.93 |
| Quality | ||||
| ROIC | 0.31% | 126.43% | 227.15% | 1,946.74% |
| Gross Margin | 0.00% | 58.16% | 0.00% | 91.52% |
| Cash Conversion Ratio | 1.43 | 0.40 | 0.90 | 1.95 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -35.85% | – | – |
| Free Cash Flow Growth | 36.02% | 66.92% | -80.72% | -199.85% |
| Safety | ||||
| Net Debt / EBITDA | -2.97 | -0.46 | -0.22 | 1.52 |
| Interest Coverage | -9.69 | -77.53 | -77.82 | -37.80 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -3,643.77 | -3,909.34 | -5,465.58 |